Savara (SVRA) Total Liabilities (2010 - 2026)

Savara's (SVRA) quarterly Total Liabilities came in at $45.6 million in Q1 2026, up 9.98% year-on-year from $41.5 million in Q1 2025, and down 9.34% on a QoQ basis from $50.3 million in Q4 2025.

Savara (SVRA) Total Liabilities (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Total Liabilities data on file, last reported at $45.6 million in Q1 2026.

  • On a quarterly basis, Total Liabilities rose 9.98% year-over-year to $45.6 million in Q1 2026; TTM through Mar 2026 was $45.6 million, a 9.98% increase from a year earlier, with the FY2025 full-year figure at $50.3 million, up 21.42% from the prior year.
  • Total Liabilities for Q1 2026 stood at $45.6 million, down from $50.3 million in the prior quarter.
  • Over the last five years, Total Liabilities for SVRA reached as high as $50.3 million in Q4 2025 and fell as low as $29.7 million in Q1 2022.
  • Historically, Total Liabilities has averaged $37.7 million across 5 years, with a median of $37.2 million in 2023.
  • Across the five-year window, Total Liabilities fell 8.54% in 2022 and rose 21.42% in 2025, its largest moves.
  • Year by year, Total Liabilities stood at $32.0 million in 2022, then increased by 16.23% to $37.2 million in 2023, then advanced by 11.39% to $41.4 million in 2024, then advanced by 21.42% to $50.3 million in 2025, then dropped by 9.34% to $45.6 million in 2026.
  • Per Business Quant data, the three most recent Total Liabilities figures were $45.6 million in Q1 2026, $50.3 million in Q4 2025, and $46.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 60.46 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 177.22 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 3.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 7.33 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 7.12 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.45 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.48 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.62 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 753.82 Mn
10 Savara 1.24 Bn 1.24 Bn - 45.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 45.61 Mn
Dec 31, 2025 50.30 Mn
Sep 30, 2025 46.54 Mn
Jun 30, 2025 43.28 Mn
Mar 31, 2025 41.47 Mn
Dec 31, 2024 41.43 Mn
Sep 30, 2024 39.47 Mn
Jun 30, 2024 37.94 Mn
Mar 31, 2024 36.43 Mn
Dec 31, 2023 37.19 Mn
Sep 30, 2023 35.53 Mn
Jun 30, 2023 32.12 Mn
Mar 31, 2023 31.10 Mn
Dec 31, 2022 32.00 Mn
Sep 30, 2022 31.24 Mn
Jun 30, 2022 29.74 Mn
Mar 31, 2022 29.73 Mn
Dec 31, 2021 32.10 Mn
Sep 30, 2021 32.05 Mn
Jun 30, 2021 31.05 Mn